Funded Tech Companies

TRIANA Biomedicines

Wondering who provided funding to TRIANA Biomedicines? Pfizer Venture Investments, Regeneron Pharmaceuticals and Invus joined the equity holders in this biopharmaceutical company.

Company Overview

Contact Information

Company Background Information

Overview

TRIANA Biomedicines is a venture-backed biopharmaceutical company leading a transformative approach to discover and develop novel small molecules to treat disease. Our technology enables us to identify molecules that promote the interaction between a target and another protein in a way that alters the fate or function of the target protein. These innovative "molecular glues" allow us to treat disease in entirely new ways by pursuing highly disease relevant targets that have long been considered undruggable or are inadequately addressed.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

12/3/2025

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Patrick Trojer

        

Chief Scientific Officer

Jean-Christophe Harmange

        

Chief Technical Officer

Jesse Chen

        

Company Investors

• Pfizer Venture Investments
• Regeneron Pharmaceuticals
• Invus
• Lightspeed Venture Partners
• Atlas Venture
• RA Capital Management
• Bessemer Venture Partners (Andrew Hedin)
• Ascenta Capital (Lorence Kim)
• YK Bioventures
• Surveyor Capital
• Logos Capital

Browse more funded tech companies:

TrialScope | Triangulate

Share this article

About Our Venture Capital Database

This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary